Form D · Biotechnology
Threat Assessment Imaging, Inc.
Scottsdale, AZ · CIK 0001787328
Offering snapshot reported Sep 9, 2019 · SEC filing
- Reported sold
- $150K Offering amount: $2.4M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $60K Reported outside-investor minimum
- First sale
- Aug 19, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 9, 2019 | Initial | $150,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 04, 06b, 04.1, 04.2, 4a5, 04.3
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-348248
Only sale is to member of Advisory Board
Source: Form D, filed Sep 9, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Nigel Barrington | Director |
| Benjamin Peter Kafka | Executive |
| Mark Gregory Morris | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10174 E Bayview Drive
Scottsdale, AZ, 85258
Scottsdale, AZ, 85258